Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-06-22

FDA Approved: FLUCONAZOLE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for fluconazole submitted by Chartwell RX, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluconazole (Fluconazole)

Snippet

SUPPL AP for FLUCONAZOLE (FLUCONAZOLE)